Institutional investors purchased a net $2.4 million shares of DNLI during the quarter ended June 2019, and now own 69.00% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CANDRIAM BELGIUM SA Bought 181.4 Thousand shares of Denali Therapeutics Inc
GLOBAL X MANAGEMENT CO. LLC Bought 32.1 Thousand shares of Denali Therapeutics Inc